A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene
Open Access
- 5 April 2023
- journal article
- case report
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 9 (1) , 1-6
Abstract
Several heterozygous variants of the glucocerebrosidase gene (GBA1) have been reported to increase the risk of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). GBA1-associated PD has been reported to be more severe than idiopathic PD, and more deleterious variants are associated with more severe clinical phenotypes. We report a family with a heterozygous p.Pro454Leu variant in GBA1. The variant was associated with a severe and rapidly progressive neurodegenerative disease with Lewy bodies that were clinically and pathologically diverse. Pathogenicity prediction algorithms and evolutionary analyses suggested that p.Pro454Leu is deleterious.Keywords
Funding Information
- Sigrid Juséliuksen Säätiö
- Yrjö Jahnssonin Säätiö
- Finnish Parkinson foundation Medical Research Center Oulu
- Oulu University Hospital
This publication has 40 references indexed in Scilit:
- GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal studyMovement Disorders, 2014
- Clinicogenetic study of GBA mutations in patients with familial Parkinson's diseaseNeurobiology of Aging, 2014
- PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related MutationsPLOS Computational Biology, 2014
- The enigma of the E326K mutation in acid β-glucocerebrosidaseMolecular Genetics and Metabolism, 2011
- Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's diseaseMolecular Genetics and Metabolism, 2011
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disordersActa Neuropathologica, 2010
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseBrain, 2009
- LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-GlucocerebrosidaseCell, 2007
- Patterns of levodopa response in Parkinson's disease: a clinico-pathological studyBrain, 2007
- ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneityHuman Molecular Genetics, 2005